Genetic Technologies (GENE) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Genetic Technologies has successfully secured a $2 million investment through a private placement of shares to sophisticated US investors, facilitated by HCW Wainwright & Co. The placement occurred without the need for public disclosure in compliance with the Corporations Act, indicating the company’s adherence to regulatory requirements.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue